Metraipolis › archive › dc_eb6b423afe05

Impact of prior immunotherapy on paclitaxel/bevacizumab in advanced non-squamous non-small cell lung cancer — Europe PMC PMID:41220941

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41220941
DOI
10.3389/fonc.2025.1675386
License (as archived)
solo-consultazione
Archived
2026-11-09T01:16:42.201Z
SHA-256 of the archived text
0e9c61188fb1e89ff2e7a1c6ad9f86a0777554e257ff2b88591f14c0f365d733
Stable URL of this page
https://metraipolis.com/documento/dc_eb6b423afe05

How to cite

Impact of prior immunotherapy on paclitaxel/bevacizumab in advanced non-squamous non-small cell lung cancer — Europe PMC PMID:41220941 — Europe PMC (en), https://europepmc.org/article/MED/41220941 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eb6b423afe05 (Metraipolis archive dc_eb6b423afe05, sha256 0e9c61188fb1e89ff2e7a1c6ad9f86a0777554e257ff2b88591f14c0f365d733)
BibTeX
@misc{dceb6b423afe05,
  title = {Impact of prior immunotherapy on paclitaxel/bevacizumab in advanced non-squamous non-small cell lung cancer — Europe PMC PMID:41220941},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41220941},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eb6b423afe05; sha256 0e9c61188fb1e89ff2e7a1c6ad9f86a0777554e257ff2b88591f14c0f365d733},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41220941. Agents can read the archived copy with the MCP tool read_document.